May 20, 2022
LETTER TO FEDERAL MINISTER OF HEALTH REGARDING PMPRB AMENDMENTS
Myeloma Canada, along with 24 signatories, wrote a letter to the Federal Health Minister, Jean-Yves Duclos, to express their strong support for the decision announced on April 14th, 2022 with regards to the Amendments to the Patented Medicines Regulations.
The implementation of the new basket of comparator countries and reduced reporting requirements for those medicines at lowest risk of excessive pricing are important to the improvement of access to quality medicines. We are pleased that the federal government is also continuing its work to streamline the approval of new drugs, develop a national strategy for drugs for rare diseases and proceed with an ambitious biomanufacturing and life sciences strategy.
Read the letter here